Trial intelligence / Profile preview

Cilostazol in Lower Limb Endovascular Treatment

NCT00912756Phase 4Unknown

Sponsor
Kansai Rosai Hospital
Start
Mar 2009
Primary completion
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cilostazol in arteriosclerosis obliterans, sponsored by Kansai Rosai Hospital. Status: unknown.

02

Drugs

cilostazol
03

Conditions

arteriosclerosis obliterans

Beyond the preview

Go deeper on NCT00912756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00912756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call